NasdaqGM:MIRMBiotechs
A Look At Mirum Pharmaceuticals (MIRM) Valuation After $600 Million Zero Coupon Convertible Note Offering
Mirum Pharmaceuticals (MIRM) has just completed a zero coupon convertible note offering of $600 million due 2032, a financing move that can reshape its capital structure and influence how investors assess the stock.
See our latest analysis for Mirum Pharmaceuticals.
Mirum’s recent zero coupon convertible note offering comes after a mixed stretch for the stock, with the share price up 26.32% year to date but down 8.24% over 90 days. The one year total shareholder return of 124.14% and five...